| Literature DB >> 21081145 |
Ruijuan Zheng1, Yan Zhou, Lianhua Qin, Ruiliang Jin, Jie Wang, Junmei Lu, WeiBing Wang, Shenjie Tang, Zhongyi Hu.
Abstract
Dendritic cell-specific intracellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) is an important receptor for Mycobacterium tuberculosis on human dendritic cells. Previous studies have shown that the variation, especially the -871A/G and -336A/G in DC-SIGN promoter influenced the susceptibility to tuberculosis. We therefore investigated whether polymorphisms in the DC-SIGN gene were associated with susceptibility to tuberculosis in an eastern Chinese population. A total of 237 culture-positive pulmonary tuberculosis case patients and 244 controls were genotyped for -871A/G and -336A/G by pyrosequencing. Our results suggested that the 2 promoter variants of DC-SIGN gene were not associated with susceptibility to tuberculosis in Chinese. Further analysis showed that the allele -336G was associated with a protective effect against fever in pulmonary tuberculosis patients, but not against cavity formation. In addition, we compared the allelic frequencies of -871A/G and -336A/G in African, Caucasian, and Asian groups. The results showed that the tw forms of allelic frequencies detected Chinese individuals in our study were similar to the reported frequencies in other Asian populations but differed significantly from those in the African and Caucasian groups studied. Copyright ÂEntities:
Mesh:
Substances:
Year: 2010 PMID: 21081145 PMCID: PMC7132724 DOI: 10.1016/j.humimm.2010.11.004
Source DB: PubMed Journal: Hum Immunol ISSN: 0198-8859 Impact factor: 2.850
Different loci selected within DC-SIGN gene and their corresponding primers used by pyrosequencing
| SNP | Locus | Primer sequence (5′→ 3′) | Temp (°C) | Product (bp) |
|---|---|---|---|---|
| −871 | rs735239 | F: bio-AAATTGGAACAACCCCGTGTC | 54 | 239 |
| R: TTCCCATTCTGAGTCTCCTTCAAA | ||||
| S: TGTTTTGTGAGATTTATCTA | ||||
| −336 | rs4804803 | F: GAGCAGTGGGATGCTTTTAATGA | 58 | 169 |
| R: bio-AGGACAGCAGCAGCTCAAA | ||||
| S: CCTCCACTAGGGCAAG |
F, forward primer; R, reverse primer; S, sequencing primer; SNP, single nucleotide polymorphism; Bio, biotin; Temp, temperature.
Frequency of DC-SIGN −336A/G and −871A/G genotypes and alleles in tuberculosis patients and controls
| Genotype/allele | Patients | Controls | OR (95% CI) | |
|---|---|---|---|---|
| SNP-871 | ||||
| A/A | 148 (62.4) | 138 (56.6) | ||
| G/G and A/G | 89 (37.6) | 106 (43.4) | 0.188 | 1.277 (0.887–1.840) |
| A | 376 (79.3) | 374 (76.6) | ||
| G | 98 (20.7) | 114 (23.4) | 0.315 | 1.169 (0.862–1.587) |
| SNP-336 | ||||
| A/A | 208 (87.8) | 209 (85.7) | ||
| G/G and A/G | 29 (12.2) | 35 (14.3) | 0.496 | 1.201 (0.708–2.037) |
| A | 445 (93.9) | 452 (92.6) | ||
| G | 29 (6.1) | 36 (7.3) | 0.437 | 1.222 (0.737–2.028) |
CI, confidence interval; OR, odds ratio.
χ2 Test for genotype distribution between patients and controls.
Haplotype distribution of −871A/G and −336A/G in tuberculosis patients and controls
| Haplotype | Haplotype frequency | OR (95% CI) | ||
|---|---|---|---|---|
| Patients | Controls | |||
| AA | 0.7321 | 0.6926 | 0.81 | 1.20 (0.808–1.781) |
| GA | 0.2068 | 0.2336 | 0.23 | 1.22 (0.880–0.680) |
| AG | 0.0612 | 0.0738 | 0.33 | 1.30 (0.770–2.200) |
Allelic distribution of DC-SIGN −871A/G and −336A/G among different populations
| Variant | Population allelic frequencies (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Chinese | Zimbabwean | Sub-Saharan African | South African black | Caucasian Canadian | Caucasian European | Thai | Asian | |
| SNP-871 | ||||||||
| A | 76.6 | 95 | 100 | 88.4 | 58 | 61.6 | 78.8 | 79.1 |
| G | 23.4 | 5 | 0 | 11.6 | 42 | 38.4 | 21.2 | 20.9 |
| | <0.001 | <0.001 | 0.041 | 0.004 | 0.021 | 0.733 | 0.733 | |
| SNP-336 | ||||||||
| A | 92.6 | 55 | 62.2 | 57.2 | 82 | 79.1 | 92 | 94.2 |
| G | 7.3 | 45 | 37.8 | 42.8 | 18 | 20.9 | 8 | 5.8 |
| | <0.001 | <0.001 | <0.001 | 0.019 | 0.004 | 0.788 | 0.774 | |
Difference between the Chinese subjects and other populations determined by χ2 test.
Analysis of DC-SIGN −336A/G and clinical features of tuberculosis
| Characteristic | Genotype frequency (%) | OR (95% CI) | ||
|---|---|---|---|---|
| AA | AG+GG | |||
| Gender | ||||
| Male | 138 (89.0) | 17 (11.0) | 0.413 | 1.392 (0.630–3.075) |
| Female | 70 (85.4) | 12 (14.6) | ||
| Age (y) | ||||
| 0–19 | 11 (100) | 0 (0) | 0.439 | |
| 20–49 | 105 (86.8) | 16 (13.2) | ||
| 50–99 | 92 (87.6) | 13 (12.4) | ||
| Fever | ||||
| No | 67 (81.7) | 15 (18.3) | 0.01 | 0.209 (0.058–0.758) |
| Yes | 64 (95.5) | 3 (4.5) | ||
| Hemoptysis | ||||
| No | 101 (87.8) | 14 (12.2) | 0.878 | 0.902 (0.240–3.389) |
| Yes | 24 (88.9) | 3 (11.1) | ||
| Cacitation | ||||
| No | 115 (90.6) | 12 (9.4) | 0.323 | 1.533 (0.654–3.592) |
| Yes | 75 (86.2) | 12 (13.8) | ||
| Treatment | ||||
| Initial treatment | 129 (89.0) | 16 (11.0) | 0.909 | 1.052 (0.442–2.504) |
| Retreatment | 69 (88.5) | 9 (11.5) | ||
| Zones affected | ||||
| 1–3 | 78 (88.6) | 10 (11.4) | 0.914 | 0.949 (0.365–2.465) |
| 4–6 | 74 (89.2) | 9 (10.8) | ||
CI, confidence interval; OR, odds ratio.